Your browser doesn't support javascript.
loading
Rare Variants in the DNA Repair Pathway and the Risk of Colorectal Cancer.
Matejcic, Marco; Shaban, Hiba A; Quintana, Melanie W; Schumacher, Fredrick R; Edlund, Christopher K; Naghi, Leah; Pai, Rish K; Haile, Robert W; Levine, A Joan; Buchanan, Daniel D; Jenkins, Mark A; Figueiredo, Jane C; Rennert, Gad; Gruber, Stephen B; Li, Li; Casey, Graham; Conti, David V; Schmit, Stephanie L.
Afiliación
  • Matejcic M; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Shaban HA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Quintana MW; Berry Consultants, Austin, Texas.
  • Schumacher FR; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio.
  • Edlund CK; Seidman Cancer Center, University Hospitals, Cleveland, Ohio.
  • Naghi L; Department of Preventive Medicine, USC Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Pai RK; Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York.
  • Haile RW; Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, Arizona.
  • Levine AJ; Department of Medicine, Research Center for Health Equity, Cedars-Sinai Samuel Oschin Comprehensive Cancer Center, Los Angeles, California.
  • Buchanan DD; Department of Medicine, Research Center for Health Equity, Cedars-Sinai Samuel Oschin Comprehensive Cancer Center, Los Angeles, California.
  • Jenkins MA; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Figueiredo JC; Victorian Comprehensive Cancer Centre, University of Melbourne, Centre for Cancer Research, Parkville, Victoria, Australia.
  • Rennert G; Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Gruber SB; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Li L; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Casey G; Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  • Conti DV; Center for Precision Medicine, City of Hope, Duarte, California.
  • Schmit SL; Department of Family Medicine, University of Virginia, Charlottesville, Virginia.
Cancer Epidemiol Biomarkers Prev ; 30(5): 895-903, 2021 05.
Article en En | MEDLINE | ID: mdl-33627384
BACKGROUND: Inherited susceptibility is an important contributor to colorectal cancer risk, and rare variants in key genes or pathways could account in part for the missing proportion of colorectal cancer heritability. METHODS: We conducted an exome-wide association study including 2,327 cases and 2,966 controls of European ancestry from three large epidemiologic studies. Single variant associations were tested using logistic regression models, adjusting for appropriate study-specific covariates. In addition, we examined the aggregate effects of rare coding variation at the gene and pathway levels using Bayesian model uncertainty techniques. RESULTS: In an exome-wide gene-level analysis, we identified ST6GALNAC2 as the top associated gene based on the Bayesian risk index (BRI) method [summary Bayes factor (BF)BRI = 2604.23]. A rare coding variant in this gene, rs139401613, was the top associated variant (P = 1.01 × 10-6) in an exome-wide single variant analysis. Pathway-level association analyses based on the integrative BRI (iBRI) method found extreme evidence of association with the DNA repair pathway (BFiBRI = 17852.4), specifically with the nonhomologous end joining (BFiBRI = 437.95) and nucleotide excision repair (BFiBRI = 36.96) subpathways. The iBRI method also identified RPA2, PRKDC, ERCC5, and ERCC8 as the top associated DNA repair genes (summary BFiBRI ≥ 10), with rs28988897, rs8178232, rs141369732, and rs201642761 being the most likely associated variants in these genes, respectively. CONCLUSIONS: We identified novel variants and genes associated with colorectal cancer risk and provided additional evidence for a role of DNA repair in colorectal cancer tumorigenesis. IMPACT: This study provides new insights into the genetic predisposition to colorectal cancer, which has potential for translation into improved risk prediction.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Predisposición Genética a la Enfermedad / Reparación del ADN Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Predisposición Genética a la Enfermedad / Reparación del ADN Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos